Pan’s Unified Biomedical Stress Field Theory ( PUSFT ): Multiscale Quantum-Classical Integration

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

We propose a revolutionary cross-scale biomedical modeling framework—Pan’s Unified Stress Field Theory ( PUSFT ), which resolves the century-old challenge of multi-scale integration through a synthesis of quantum, classical, and symbolic methodologies. The theory’s governing equation unifies six biological scales (denoted as k∈{1,…,6}) via a mathematical formulation that integrates quantum operators, classical stress tensors, and evolutionary phase dynamics (Equation 1):Key experimental validations highlight the framework’s transformative potential:· Phase-locked metabolic tracking enables early prediction of drug resistance 5.7 ± 0.3 months ahead of clinical manifestation (ΔAUC = +0.25 vs conventional methods, P <0.001; 95% CI: 0.21–0.29).· Quantum-enhanced AXB field analysis detects pancreatic adenocarcinoma gradients with 92 ± 2% specificity (F1 -score = 0.89,  n = 10000 samples).· Real-time clinical integration reduces therapeutic decision latency from 28.7 days to 2.3 ± 0.5 days (HR = 0.39; 95% CI: 0.32–0.47).Therapeutic optimization framework (T = 6 months observation window) (Equation 2):incorporates a novel integral equation (Equation 2) over a 6-month observation window. This approach overcomes the exponential complexity barrier ( τsim ∝ e N 1.2 ) inherent in molecular dynamics simulations (N > 1000000 atoms atoms), enabling seamless integration across scales—from quantum biological processes (0.1 nm) to clinical ecosystems (1 km).Validation spans two domains:1.1024-dimensional quantum state simulations (see Theorem 1 for existence proofs).2.OMOP-CDM clinical datasets (N =107 patients, illustrated in Figure 3).Innovation-Correlation MapThe framework achieves three foundational unifications:·Quantum protein folding (Algorithm 1: DRL Policy Algorithm) ↔ Clinical trial outcomes (Table 1: Clinical Benchmark).·1 ms molecular imaging ↔ 5-year survival rates ( Figure 5: PDAC Survival Analysis )·Individual drug response ( 1000 features ) ↔ Population health ( 10000000 samples ).This work establishes a paradigm for cross-scale biomedical modeling, bridging previously disconnected domains from atomic-level interactions to global healthcare systems.

Article activity feed